Results 141 to 150 of about 42,175 (206)

Pancreatic Mucinous Cystic Neoplasms Following GLP-1 Receptor Agonists Use: A Report of Two Cases with Literature Review. [PDF]

J Gastrointest Cancer
Alsaleh NM, Abo Alshamat R, Almrzouqi W, Alhebshi M, Aljuhani T, Almahdi R, Almaghrabi M, Rammal A, Ageel A, Alzahrani MA.   +9 more
europepmc   +1 more source

Exploring and expanding the chemical multiverse of peptides. [PDF]

Chem Sci
López-López E, Sánchez-Castañeda JP, Martinez-Cortés MS, de la Fuente-Nunez C, Medina-Franco JL.   +4 more
europepmc   +1 more source

Tests on Three Antisera und Subsequent Development of Radioimmunoassay for Different Regions of Human parathyrin [PDF]

, 1979
Marschner, I., Scriba, Peter Christian, Wood, W. G.   +2 more
core  

Engineering a Glucose-Responsive Glucagon Prodrug Through Arginine-Phenylboronic Acid Pendant Modification. [PDF]

Small Sci
DeWolf EL, Chen W, Webber B, Power EM, Kilmer R, Kadu P, Xian S, Webber MJ.   +7 more
europepmc   +1 more source

New developments in GLP-1 agonist therapy for gestational diabetes: Systematic review on liraglutide, semaglutide, and exenatide from ClinicalTrials.gov. [PDF]

Medicine (Baltimore)
Alshehri FS.
europepmc   +1 more source

Deciphering obesity: a conceptual overview and synthesis. [PDF]

Front Endocrinol (Lausanne)
Prakash R, Arora A, Khan A.
europepmc   +1 more source

Differential association of hyperglucagonemia with C-peptide levels in diabetic ketosis/ketoacidosis and hyperosmolar hyperglycemic state. [PDF]

Diabetol Int
Iida T, Nii S, Nishikawa H, Kodama E, Imai H, Hashizume M, Tadokoro R, Sugisawa C, Iizaka T, Otsuka F, Nagasaka S.   +10 more
europepmc   +1 more source

Association of fasting plasma glucagon with osteopenia/osteoporosis in Chinese patients with type 2 diabetes. [PDF]

BMC Endocr Disord
Zhang L, Zhang P, Shi R.
europepmc   +1 more source

Assessing the shadows: A meta-analysis of GLP-1 agonists and suicidal ideation. [PDF]

Medicine (Baltimore)
Alansari AO, Alharbi AS, Alshehri KM, Alhabib AT, Alsalmi BS, Almosfer WA, AlAjlan FA, Alharbi AA, Alzahrani BS, Alamer B, Alatawi AM.   +10 more
europepmc   +1 more source

Pharmacological therapies for type 2 diabetes: future approaches. [PDF]

Diabetologia
Bailey CJ.
europepmc   +1 more source